APT Medical Inc688617
Mentioned
Impact on stocks 1
Others
APT Medical IncHuiTai Medical first-half net profit attributable to parent 537 million yuan, up 26.4% year on year
Earnings
HuiTai Medical released its 2026 half-year report. First-half net profit attributable to the parent was 537 million yuan, up 26.4% year on year. Operating revenue was 1.53 billion yuan, up 25.75% year on year. Net profit attributable to the parent after deducting non-recurring items was 529 million yuan, up 28.7% year on year. Net operating cash flow was 549 million yuan, up 23.5% year on year. Second-quarter operating revenue was 822 million yuan, up 26.6% year on year, and net profit attributable to the parent was 308 million yuan, up 27.2% year on year. The company said competition in the electrophysiology device market has intensified, but obtaining the registration certificate for the magnetic positioning pressure-sensing ablation catheter has broken the monopoly of imported manufacturers in the field of atrial fibrillation treatment.
APT Medical Inc